These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24874283)

  • 1. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel.
    Lødrup A; Reimer C; Bytzer P
    Scand J Gastroenterol; 2014 Sep; 49(9):1044-50. PubMed ID: 24874283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Efficacy of a Pure Alginate Formulation (Lamina G) for Controlling Symptoms in Individuals with Reflux Symptoms: A Randomized Clinical Study.
    Kim JH; Lee YC; Kim EH; Park JC; Shin SK; Lee SK; Jung DH; Park JJ; Youn YH; Park H
    Gut Liver; 2019 Nov; 13(6):642-648. PubMed ID: 30970442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient selection for therapy reduction after long-term daily proton pump inhibitor treatment for gastro-oesophageal reflux disease: trial and error.
    van der Velden AW; de Wit NJ; Quartero AO; Grobbee DE; Numans ME
    Digestion; 2013; 87(2):85-90. PubMed ID: 23364219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing Patterns of Proton Pump Inhibitors in Germany: A Retrospective Study Including 472 146 Patients.
    Plehhova K; Haering M; Wray J; Coyle C; Ibáñez E; Kostev K
    J Prim Care Community Health; 2023; 14():21501319231221002. PubMed ID: 38142444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
    Coyle C; Crawford G; Wilkinson J; Thomas SJ; Bytzer P
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1524-1533. PubMed ID: 28464343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease.
    Rohof WO; Bennink RJ; Smout AJ; Thomas E; Boeckxstaens GE
    Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1585-91; quiz e90. PubMed ID: 23669304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alginate on demand as add-on for patients with gastro-oesophageal reflux disease and insufficient PPI effect].
    Müller M; Labenz G; Borkenstein DP; Labenz J;
    Dtsch Med Wochenschr; 2019 Feb; 144(4):e30-e35. PubMed ID: 30466131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alginate therapy is effective treatment for gastroesophageal reflux disease symptoms: a systematic review and meta-analysis.
    Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27671545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gastroesophageal reflux in the French general population: national survey of 8000 adults].
    Bretagne JF; Richard-Molard B; Honnorat C; Caekaert A; Barthélemy P
    Presse Med; 2006 Jan; 35(1 Pt 1):23-31. PubMed ID: 16462660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.
    Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
    Dis Esophagus; 2017 May; 30(5):1-9. PubMed ID: 28375448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.
    Quartarone G
    Minerva Ginecol; 2013 Oct; 65(5):541-9. PubMed ID: 24096290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow up in patients with gastroesophageal reflux disease with specific emphasis on reflux symptoms, use of anti-reflux medication and anti-reflux surgery outcome: a retrospective study.
    Van Meer S; Bogte A; Siersema PD
    Scand J Gastroenterol; 2013 Nov; 48(11):1242-8. PubMed ID: 24041112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
    Raghunath AS; Hungin AP; Mason J; Jackson W
    Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.
    Ruigómez A; Johansson S; Wernersson B; Fernández Cantero O; García Rodríguez LA
    Scand J Gastroenterol; 2012 Jul; 47(7):751-61. PubMed ID: 22519917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal Protective Compounds in the Treatment of Gastroesophageal Reflux Disease. A Position Paper Based on Evidence of the Romanian Society of Neurogastroenterology.
    Surdea-Blaga T; Băncilă I; Dobru D; Drug V; Frățilă O; Goldiș A; Grad SM; Mureșan C; Nedelcu L; Porr PJ; Sporea I; Dumitrascu DL
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):537-546. PubMed ID: 27981311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge gaps in the management of refractory reflux-like symptoms: Healthcare provider survey.
    Armstrong D; Hungin AP; Kahrilas PJ; Sifrim D; Sinclair P; Vaezi MF; Sharma P
    Neurogastroenterol Motil; 2022 Oct; 34(10):e14387. PubMed ID: 35502888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of gastroesophageal reflux with an original preparation containing alginate/antacid or pectinate/antacid].
    Stanciu C; Bălan G; Cijevschi C; Sănduiescu E; Frasin M; Filimon L; Ariton S; Busuioc I; Taraşi G
    Rev Med Chir Soc Med Nat Iasi; 1985; 89(2):233-6. PubMed ID: 4089324
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and safety of alginate formulations in patients with gastroesophageal reflux disease: a systematic review and meta-analysis of randomized controlled trials.
    Zhao CX; Wang JW; Gong M
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11845-11857. PubMed ID: 33275256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.